BVF Inc’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,193,224
| Closed | -$55.3M | – | 63 |
|
|
2019
Q2 | $55.3M | Sell |
1,193,224
-2,227,338
| -65% | -$62.5M | 6.04% | 3 |
|
|
2019
Q1 | $83.4M | Sell |
3,420,562
-1,323,500
| -28% | -$27.6M | 9.34% | 1 |
|
|
2018
Q4 | $67.6M | Sell |
4,744,062
-1,546,524
| -25% | -$23.5M | 8.83% | 2 |
|
|
2018
Q3 | $95.6M | Buy |
6,290,586
+1,618,391
| +35% | +$24.8M | 8.4% | 1 |
|
|
2018
Q2 | $78.4M | Sell |
4,672,195
-390,573
| -8% | -$6.21M | 7.65% | 3 |
|
|
2018
Q1 | $82.6M | Sell |
5,062,768
-3,623,730
| -42% | -$58M | 8.38% | 3 |
|
|
2017
Q4 | $111M | Buy |
8,686,498
+2,283,973
| +36% | +$26M | 13.4% | 1 |
|
|
2017
Q3 | $78.8M | Buy |
6,402,525
+342,900
| +6% | +$3.18M | 10.01% | 1 |
|
|
2017
Q2 | $50.7M | Buy |
6,059,625
+3,296,539
| +119% | +$27M | 7.88% | 3 |
|
|
2017
Q1 | $24.7M | Sell |
2,763,086
-2,223,100
| -45% | -$23.7M | 4.2% | 9 |
|
|
2016
Q4 | $43.8M | Sell |
4,986,186
-1,475,000
| -23% | -$10.9M | 8.81% | 4 |
|
|
2016
Q3 | $43.6M | Sell |
6,461,186
-1,799,711
| -22% | -$6.96M | 8.22% | 4 |
|
|
2016
Q2 | $29.4M | Buy |
8,260,897
+410,686
| +5% | +$1.34M | 6.27% | 6 |
|
|
2016
Q1 | $23.2M | Buy |
7,850,211
+1,167,500
| +17% | +$3.5M | 5.73% | 7 |
|
|
2015
Q4 | $28.2M | Sell |
6,682,711
-2,997,919
| -31% | -$13.7M | 4.81% | 9 |
|
|
2015
Q3 | $44.1M | Buy |
9,680,630
+511,354
| +6% | +$3.03M | 8.92% | 4 |
|
|
2015
Q2 | $66.1M | Sell |
9,169,276
-236,541
| -3% | -$1.75M | 11.67% | 1 |
|
|
2015
Q1 | $69.3M | Sell |
9,405,817
-2,366,518
| -20% | -$16.8M | 14.5% | 1 |
|
|
2014
Q4 | $55.7M | Sell |
11,772,335
-2,104,178
| -15% | -$8.32M | 10.83% | 3 |
|
|
2014
Q3 | $49.5M | Sell |
13,876,513
-839,273
| -6% | -$3.31M | 10.29% | 4 |
|
|
2014
Q2 | $67.1M | Buy |
14,715,786
+6,228,859
| +73% | +$25.8M | 10.61% | 3 |
|
|
2014
Q1 | $39.9M | Buy |
8,486,927
+933,838
| +12% | +$4.7M | 6.18% | 5 |
|
|
2013
Q4 | $37.8M | Sell |
7,553,089
-2,166,500
| -22% | -$11.8M | 6.62% | 5 |
|
|
2013
Q3 | $60.5M | Sell |
9,719,589
-1,412,269
| -13% | -$8.39M | 10.4% | 3 |
|
|
2013
Q2 | $50.5M | Buy |
+11,131,858
| New | +$59.9M | 9.81% | 4 |
|
Other funds holding ARRY
BVF Inc's ARRY Position: Q3 2019 in Review
BVF Inc sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,193,224 shares — an estimated $55.3M sold.
BVF Inc first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $111M in Q4 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- BVF Inc reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- BVF Inc sold 1,193,224 Array Biopharma Inc shares in Q3 2019, an estimated $55.3M.
- BVF Inc first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- BVF Inc's Array Biopharma Inc position peaked at $111M in Q4 2017.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on BVF Inc's 13F filing for Q3 2019, filed 14 Nov 2019.